# Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody

> **NCT06653907** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yang ZHANG** · enrollment: 400 (estimated)

## Conditions studied

- Thyroid Abnormalities
- Pregnant Woman
- Pregnancy Outcomes

## Interventions

- **DRUG:** Levothyroxine Sodium (LT4) Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06653907
- **Lead sponsor:** Yang ZHANG
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-10-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2024-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06653907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06653907, "Levothyroxine Intervention in Pregnant Women with TSH （2.5 MIU/L-upper Limit of Reference Range） and Negative Thyroid Peroxidase Antibody". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06653907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*